James L. Rogers

Array ( [id] => 6188843 [patent_doc_number] => 20110171688 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-14 [patent_title] => 'METHOD OF PROVIDING IMMUNOGLOBULIN SECRETING B LYMPHOCYTES AND HUMAN ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 12/991422 [patent_app_country] => US [patent_app_date] => 2009-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7185 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20110171688.pdf [firstpage_image] =>[orig_patent_app_number] => 12991422 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8201554 [patent_doc_number] => 08188235 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-29 [patent_title] => 'Antibodies to IL-6 and their uses' [patent_app_type] => utility [patent_app_number] => 12/480991 [patent_app_country] => US [patent_app_date] => 2009-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 31158 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/188/08188235.pdf [firstpage_image] =>[orig_patent_app_number] => 12480991 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5972513 [patent_doc_number] => 20110152202 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-23 [patent_title] => 'DEVELOPMENT OF C-REACTIVE PROTEIN MUTANT WITH IMPROVED THERAPEUTIC BENEFIT IN IMMUNE THROMBOCYTOPENIA AND LUPUS NEPHRITIS' [patent_app_type] => utility [patent_app_number] => 12/995828 [patent_app_country] => US [patent_app_date] => 2009-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8115 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20110152202.pdf [firstpage_image] =>[orig_patent_app_number] => 12995828 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5972513 [patent_doc_number] => 20110152202 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-23 [patent_title] => 'DEVELOPMENT OF C-REACTIVE PROTEIN MUTANT WITH IMPROVED THERAPEUTIC BENEFIT IN IMMUNE THROMBOCYTOPENIA AND LUPUS NEPHRITIS' [patent_app_type] => utility [patent_app_number] => 12/995828 [patent_app_country] => US [patent_app_date] => 2009-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8115 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20110152202.pdf [firstpage_image] =>[orig_patent_app_number] => 12995828 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5302881 [patent_doc_number] => 20090297533 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-03 [patent_title] => 'CONTROLLED RELEASE IMMUNOMODULATOR COMPOSITIONS AND METHODS FOR THE TREATMENT OF OTIC DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/472034 [patent_app_country] => US [patent_app_date] => 2009-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 56113 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0297/20090297533.pdf [firstpage_image] =>[orig_patent_app_number] => 12472034 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5945105 [patent_doc_number] => 20110105725 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-05 [patent_title] => 'ANTIBODY PURIFICATION PROCESS' [patent_app_type] => utility [patent_app_number] => 12/992661 [patent_app_country] => US [patent_app_date] => 2009-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11933 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20110105725.pdf [firstpage_image] =>[orig_patent_app_number] => 12992661 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9350462 [patent_doc_number] => 08669353 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-03-11 [patent_title] => 'Process for producing milk fractions rich in secretory immunoglobulins' [patent_app_type] => utility [patent_app_number] => 12/992701 [patent_app_country] => US [patent_app_date] => 2009-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 7849 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 119 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12992701 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6420052 [patent_doc_number] => 20100150908 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-17 [patent_title] => 'Affinity matured CRIg variants' [patent_app_type] => utility [patent_app_number] => 12/387794 [patent_app_country] => US [patent_app_date] => 2009-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 18331 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0150/20100150908.pdf [firstpage_image] =>[orig_patent_app_number] => 12387794 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9060107 [patent_doc_number] => 08546542 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-01 [patent_title] => 'Anti-sweat antigen monoclonal antibody' [patent_app_type] => utility [patent_app_number] => 12/990775 [patent_app_country] => US [patent_app_date] => 2009-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 17 [patent_no_of_words] => 15482 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12990775 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6102833 [patent_doc_number] => 20110166326 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-07 [patent_title] => 'FILTRATION METHOD' [patent_app_type] => utility [patent_app_number] => 12/993512 [patent_app_country] => US [patent_app_date] => 2009-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7690 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20110166326.pdf [firstpage_image] =>[orig_patent_app_number] => 12993512 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7697130 [patent_doc_number] => 20110229460 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-22 [patent_title] => ' ANTI-CD137 ANTIBODY AS AN AGENT IN THE TREATMENT OF INFLAMMATORY CONDITIONS' [patent_app_type] => utility [patent_app_number] => 12/990554 [patent_app_country] => US [patent_app_date] => 2009-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 19298 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20110229460.pdf [firstpage_image] =>[orig_patent_app_number] => 12990554 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10594501 [patent_doc_number] => 09315577 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-04-19 [patent_title] => 'Anti-hepcidin antibodies and methods of use' [patent_app_type] => utility [patent_app_number] => 12/990137 [patent_app_country] => US [patent_app_date] => 2009-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 46 [patent_no_of_words] => 48436 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 134 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12990137 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6001766 [patent_doc_number] => 20110117605 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-19 [patent_title] => 'Methods for Manufacturing a Polyclonal Protein' [patent_app_type] => utility [patent_app_number] => 12/989340 [patent_app_country] => US [patent_app_date] => 2009-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 17572 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0117/20110117605.pdf [firstpage_image] =>[orig_patent_app_number] => 12989340 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9582458 [patent_doc_number] => 08772461 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-07-08 [patent_title] => 'Two-stage ultrafiltration/diafiltration' [patent_app_type] => utility [patent_app_number] => 12/937454 [patent_app_country] => US [patent_app_date] => 2009-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 6842 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 169 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12937454 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6055046 [patent_doc_number] => 20110111406 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-12 [patent_title] => 'ANTIGEN-BINDING MOLECULE CAPABLE OF BINDING TO TWO OR MORE ANTIGEN MOLECULES REPEATEDLY' [patent_app_type] => utility [patent_app_number] => 12/936587 [patent_app_country] => US [patent_app_date] => 2009-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 51415 [patent_no_of_claims] => 65 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20110111406.pdf [firstpage_image] =>[orig_patent_app_number] => 12936587 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7487424 [patent_doc_number] => 20110236381 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-29 [patent_title] => 'INHIBITION OF INTER-ALPHA TRYPSIN INHIBITOR FOR THE TREATMENT OF AIRWAY DISEASE' [patent_app_type] => utility [patent_app_number] => 13/133000 [patent_app_country] => US [patent_app_date] => 2009-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 24165 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0236/20110236381.pdf [firstpage_image] =>[orig_patent_app_number] => 13133000 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5958523 [patent_doc_number] => 20110182910 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-28 [patent_title] => 'METHOD OF TREATING T CELL MEDIATED DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/921308 [patent_app_country] => US [patent_app_date] => 2009-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 16154 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20110182910.pdf [firstpage_image] =>[orig_patent_app_number] => 12921308 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9831489 [patent_doc_number] => 08940299 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-01-27 [patent_title] => 'Method of treating cancer' [patent_app_type] => utility [patent_app_number] => 12/920293 [patent_app_country] => US [patent_app_date] => 2009-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 25 [patent_no_of_words] => 12350 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12920293 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6008100 [patent_doc_number] => 20110060131 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-10 [patent_title] => 'MONOSPECIFIC ANTIBODY AND METHOD OF PRODUCTION USING AS ANTIGEN AN ISOFORM OF THE HUMAN FAD SYNTHETASE' [patent_app_type] => utility [patent_app_number] => 12/919233 [patent_app_country] => US [patent_app_date] => 2009-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2378 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0060/20110060131.pdf [firstpage_image] =>[orig_patent_app_number] => 12919233 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6024199 [patent_doc_number] => 20110052525 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-03 [patent_title] => 'Breaking Immunological Tolerance with a Genetically Encoded Unnatural Amino Acid' [patent_app_type] => utility [patent_app_number] => 12/735575 [patent_app_country] => US [patent_app_date] => 2009-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 53803 [patent_no_of_claims] => 121 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20110052525.pdf [firstpage_image] =>[orig_patent_app_number] => 12735575 [rel_patent_id] =>[rel_patent_doc_number] =>)